• OPEN AN ACCOUNT
Indian Indices
Sensex
77,412.67 -315.49
( -0.41%)
Global Indices
Nasdaq
53,489.46 -263.95
(-0.49%)
Dow Jones
7,767.06 -39.70
(-0.51%)
Hang Seng
69,148.70 434.90
(0.63%)
Nikkei 225
10,727.81 -22.30
(-0.21%)
Forex
USD-INR
95.53 0.14
(0.14%)
EUR-INR
110.53 0.55
(0.50%)
GBP-INR
129.27 0.59
(0.46%)
JPY-INR
0.60 0.00
(0.19%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
163.1433353
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
FREDUN
54.09
2403.56
EPS(TTM)
Face Value()
Div & Yield %
26.87
10
0.02
 

Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
May 29,2026
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.7310.43 -13.9212.16 -
PBDT14.409.10 58 55.2432.53 70
PBT11.257.26 55 47.0027.49 71
NP10.786.00 80 32.6219.74 65